# Safety and Feasibility of ActivSightTM in Human

> **NCT04633512** · NA · UNKNOWN · sponsor: **Activ Surgical** · enrollment: 67 (estimated)

## Conditions studied

- Acute Cholecystitis
- Colorectal Cancer
- Diverticulitis, Colonic
- Obesity, Morbid
- Inflammatory Bowel Diseases

## Interventions

- **DEVICE:** ActivSight

## Key facts

- **NCT ID:** NCT04633512
- **Lead sponsor:** Activ Surgical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-17
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 67 (ESTIMATED)
- **Last updated:** 2024-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04633512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04633512, "Safety and Feasibility of ActivSightTM in Human". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04633512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*